ARTICLE | Company News
Vertex, Glaxo Wellcome, Kissei Pharmaceutical deal
January 15, 1996 8:00 AM UTC
VRTX earned $5 million in milestone and option fees from Glaxo and Kissei in December related to the development of the company's VX-478 HIV protease inhibitor. ...